BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 38506227)

  • 1. Evaluation of the tumor-targeting specific imaging and killing effect of a CEA-targeting nanoparticle in colorectal cancer.
    Feng Q; Wang SA; Ning B; Xie J; Ding J; Liu S; Ai S; Li F; Wang X; Guan W
    Biochem Biophys Res Commun; 2024 Jul; 719():150084. PubMed ID: 38733742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of CEA-targeting Nanoparticles for Drug Delivery in Colorectal Cancer.
    Sousa AR; Oliveira MJ; Sarmento B
    J Pharmacol Exp Ther; 2019 Sep; 370(3):657-670. PubMed ID: 30670480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoembryonic Antigen (CEA) and Hepatic Metastasis in Colorectal Cancer: Update on Biomarker for Clinical and Biotechnological Approaches.
    Campos-da-Paz M; Dórea JG; Galdino AS; Lacava ZGM; de Fatima Menezes Almeida Santos M
    Recent Pat Biotechnol; 2018; 12(4):269-279. PubMed ID: 30062978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photoactive imaging and therapy for colorectal cancer using a CEA-Affimer conjugated Foslip nanoparticle.
    Khaled YS; Khot MI; Aiyappa-Maudsley R; Maisey T; Pramanik A; Tiernan J; Lintern N; Al-Enezi E; Shamsuddin SH; Tomlinson D; Coletta L; Millner PA; Hughes TA; Jayne DG
    Nanoscale; 2024 Apr; 16(14):7185-7199. PubMed ID: 38506227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescent imaging using novel conjugated polymeric nanoparticles-affimer probes in complex
    Jolugbo P; Willott T; Lin WH; Maisey T; O'Callaghan D; Green MA; Jayne DG; Khot MI
    Nanoscale; 2023 Aug; 15(30):12476-12480. PubMed ID: 37466243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CEA loaded maghemite nanoparticles as a theragnostic device for colorectal cancer.
    da Paz MC; Santos Mde F; Santos CM; da Silva SW; de Souza LB; Lima EC; Silva RC; Lucci CM; Morais PC; Azevedo RB; Lacava ZG
    Int J Nanomedicine; 2012; 7():5271-82. PubMed ID: 23055733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CEA-targeted nanoparticles allow specific in vivo fluorescent imaging of colorectal cancer models.
    Tiernan JP; Ingram N; Marston G; Perry SL; Rushworth JV; Coletta PL; Millner PA; Jayne DG; Hughes TA
    Nanomedicine (Lond); 2015; 10(8):1223-31. PubMed ID: 25694062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice.
    Sundaresan G; Yazaki PJ; Shively JE; Finn RD; Larson SM; Raubitschek AA; Williams LE; Chatziioannou AF; Gambhir SS; Wu AM
    J Nucl Med; 2003 Dec; 44(12):1962-9. PubMed ID: 14660722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances in Functionalized Nanoparticles in Cancer Theranostics.
    Siddique S; Chow JCL
    Nanomaterials (Basel); 2022 Aug; 12(16):. PubMed ID: 36014691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing Incidence of Early-Onset Colorectal Cancer.
    Sinicrope FA
    N Engl J Med; 2022 Apr; 386(16):1547-1558. PubMed ID: 35443109
    [No Abstract]   [Full Text] [Related]  

  • 11. Affimer Tagged Cubosomes: Targeting of Carcinoembryonic Antigen Expressing Colorectal Cancer Cells Using
    Pramanik A; Xu Z; Shamsuddin SH; Khaled YS; Ingram N; Maisey T; Tomlinson D; Coletta PL; Jayne D; Hughes TA; Tyler AII; Millner PA
    ACS Appl Mater Interfaces; 2022 Mar; 14(9):11078-11091. PubMed ID: 35196008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposome Photosensitizer Formulations for Effective Cancer Photodynamic Therapy.
    Fahmy SA; Azzazy HME; Schaefer J
    Pharmaceutics; 2021 Aug; 13(9):. PubMed ID: 34575424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns and resectability of colorectal cancer recurrences: outcome study within the COLOFOL trial.
    Hansdotter P; Scherman P; Petersen SH; Mikalonis M; Holmberg E; Rizell M; Naredi P; Syk I
    BJS Open; 2021 Jul; 5(4):. PubMed ID: 34308474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global colorectal cancer burden in 2020 and projections to 2040.
    Xi Y; Xu P
    Transl Oncol; 2021 Oct; 14(10):101174. PubMed ID: 34243011
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.